PORD
MCID: CYT014
MIFTS: 33

Cytochrome P450 Oxidoreductase Deficiency (PORD)

Categories: Bone diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Cytochrome P450 Oxidoreductase Deficiency

MalaCards integrated aliases for Cytochrome P450 Oxidoreductase Deficiency:

Name: Cytochrome P450 Oxidoreductase Deficiency 24 25
Antley-Bixler Syndrome with Disordered Steroidogenesis 25 72
Por Deficiency 24 25
Pord 24 25
Congenital Adrenal Hyperplasia Due to Apparent Combined P450c17 and P450c21 Deficiency 25
Antley-Bixler Syndrome-Like Phenotype with Disordered Steroidogenesis 25
Combined Partial Deficiency of 17-Hydroxylase and 21-Hydroxylase 25
Antley-Bixler Syndrome, Autosomal Dominant 72
Antley-Bixler Syndrome 25

Classifications:



External Ids:

UMLS 72 C1860042 C2936791

Summaries for Cytochrome P450 Oxidoreductase Deficiency

Genetics Home Reference : 25 Cytochrome P450 oxidoreductase deficiency is a disorder of hormone production. This condition specifically affects steroid hormones, which are needed for normal development and reproduction. The hormonal changes associated with cytochrome P450 oxidoreductase deficiency can affect the development of the reproductive system, skeleton, and other parts of the body. These signs and symptoms are usually present at birth or become apparent in early childhood. The signs and symptoms of cytochrome P450 oxidoreductase deficiency vary from mild to severe. Signs and symptoms of mild cases can include a failure to begin menstruation by age 16 (primary amenorrhea), an inability to have biological children (infertility) in both men and women, and a condition called polycystic ovarian syndrome (PCOS). PCOS is characterized by a hormonal imbalance in women that can lead to irregular menstruation, acne, excess body hair (hirsutism), and weight gain. People with moderate cases of cytochrome P450 oxidoreductase deficiency may have external genitalia that do not look clearly male or female (ambiguous genitalia), and they may have infertility. People with moderate cytochrome P450 oxidoreductase deficiency usually do not have skeletal abnormalities. The severe form of cytochrome P450 oxidoreductase deficiency is sometimes called Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis. Hormonal changes in affected males and females lead to the development of ambiguous genitalia or other genital abnormalities, as well as infertility. Severe cases are also characterized by skeletal abnormalities, particularly involving bones of the head and face. These include premature fusion of the skull bones (craniosynostosis), a flattened mid-face, a prominent forehead, and low-set ears. Other skeletal abnormalities can include joint deformities (contractures) that limit movement; unusually long, slender fingers (arachnodactyly); bowing of the thigh bones; and radiohumeral synostosis, which is a bone abnormality that locks the elbows in a bent position. A blockage of the nasal passages (choanal atresia), intellectual disability, and delayed development are also associated with the severe form of the disorder. Some women who are pregnant with fetuses affected by cytochrome P450 oxidoreductase deficiency experience mild symptoms of the disorder even though they themselves do not have the disorder. They may develop excessive body hair growth (hirsutism), acne, and a deep voice. These changes go away soon after delivery.

MalaCards based summary : Cytochrome P450 Oxidoreductase Deficiency, also known as antley-bixler syndrome with disordered steroidogenesis, is related to luteoma and antley-bixler syndrome without genital anomalies or disordered steroidogenesis. An important gene associated with Cytochrome P450 Oxidoreductase Deficiency is POR (Cytochrome P450 Oxidoreductase), and among its related pathways/superpathways are Cytochrome P450 - arranged by substrate type and Aldosterone synthesis and secretion. Affiliated tissues include bone, testes and liver, and related phenotypes are behavior/neurological and liver/biliary system

GeneReviews: NBK1419

Related Diseases for Cytochrome P450 Oxidoreductase Deficiency

Diseases related to Cytochrome P450 Oxidoreductase Deficiency via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 88)
# Related Disease Score Top Affiliating Genes
1 luteoma 30.2 FGFR2 CYP21A2
2 antley-bixler syndrome without genital anomalies or disordered steroidogenesis 29.9 POR FGFR2
3 hyperandrogenism 29.9 POMC CYP21A2 CYP17A1
4 polycystic ovary syndrome 29.5 CYP21A2 CYP17A1
5 lipoid congenital adrenal hyperplasia 29.5 POR POMC CYP21A2 CYP17A1
6 hypospadias 29.4 FGFR2 CYP17A1
7 antley-bixler syndrome 29.2 POR FGFR2 CYP21A2 CYP17A1
8 disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency 13.2
9 aromatase deficiency 12.0
10 antley-bixler syndrome with genital anomalies and disordered steroidogenesis 12.0
11 bartter syndrome, type 2, antenatal 11.6
12 bartter syndrome, type 1, antenatal 11.6
13 choanal atresia, posterior 10.8
14 pfeiffer syndrome 10.6
15 fgfr-related craniosynostosis syndromes 10.6
16 familial glucocorticoid deficiency 10.6
17 humeroradial synostosis 10.6
18 radioulnar synostosis 10.5
19 trigonocephaly 1 10.5
20 chiari malformation type ii 10.5
21 respiratory failure 10.5
22 clubfoot 10.5
23 ankylosis 10.5
24 chiari malformation 10.5
25 congenital radioulnar synostosis 10.5
26 ramer ladda syndrome 10.5
27 isolated trigonocephaly 10.5
28 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 10.4
29 cleft palate, isolated 10.3
30 clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly 10.3
31 jackson-weiss syndrome 10.3
32 crouzon syndrome 10.3
33 tracheoesophageal fistula with or without esophageal atresia 10.3
34 down syndrome 10.3
35 renal hypodysplasia/aplasia 1 10.3
36 alacrima, achalasia, and mental retardation syndrome 10.3
37 bone disease 10.3
38 esophageal atresia 10.3
39 hydronephrosis 10.3
40 obstructive hydrocephalus 10.3
41 hypogonadism 10.3
42 dysostosis 10.3
43 hemangioma 10.3
44 hypogonadotropism 10.3
45 chromosomal triplication 10.3
46 congenital femoral deficiency 10.3
47 fetal aminopterin syndrome 10.3
48 lambdoid synostosis 10.3
49 talipes equinovarus 10.3
50 vaginal atresia 10.3

Graphical network of the top 20 diseases related to Cytochrome P450 Oxidoreductase Deficiency:



Diseases related to Cytochrome P450 Oxidoreductase Deficiency

Symptoms & Phenotypes for Cytochrome P450 Oxidoreductase Deficiency

MGI Mouse Phenotypes related to Cytochrome P450 Oxidoreductase Deficiency:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.55 CYP17A1 CYP1A2 FGFR2 POMC POR
2 liver/biliary system MP:0005370 9.26 CYP1A2 FGFR2 POMC POR
3 renal/urinary system MP:0005367 8.8 FGFR2 POMC POR

Drugs & Therapeutics for Cytochrome P450 Oxidoreductase Deficiency

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Investigations Into Inborn Errors of Cholesterol Synthesis and Related Disorders Recruiting NCT00046202

Search NIH Clinical Center for Cytochrome P450 Oxidoreductase Deficiency

Genetic Tests for Cytochrome P450 Oxidoreductase Deficiency

Anatomical Context for Cytochrome P450 Oxidoreductase Deficiency

MalaCards organs/tissues related to Cytochrome P450 Oxidoreductase Deficiency:

41
Bone, Testes, Liver, Lung, Fetal Lung, Temporal Lobe

Publications for Cytochrome P450 Oxidoreductase Deficiency

Articles related to Cytochrome P450 Oxidoreductase Deficiency:

(show top 50) (show all 92)
# Title Authors PMID Year
1
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms. 38 4
27068427 2017
2
Long-term follow-up of a female with congenital adrenal hyperplasia due to P450-oxidoreductase deficiency. 38 4
27737328 2016
3
Pharmacogenomics of human P450 oxidoreductase. 38 4
24847272 2014
4
Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency. 38 4
23365120 2013
5
Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 38 4
22162478 2012
6
Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. 38 4
19258400 2009
7
Predictive value of fetal lung volume in prenatally diagnosed skeletal dysplasia. 4
25102973 2014
8
Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia. 4
24585534 2014
9
Proximal promoter of the cytochrome P450 oxidoreductase gene: identification of microdeletions involving the untranslated exon 1 and critical function of the SP1 binding sites. 4
21900384 2011
10
Craniosynostosis and multiple skeletal anomalies in humans and zebrafish result from a defect in the localized degradation of retinoic acid. 4
22019272 2011
11
Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 4
21190981 2011
12
Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. 4
20844025 2010
13
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. 4
20697309 2010
14
Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. 4
20849814 2010
15
Restoration of mutant cytochrome P450 reductase activity by external flavin. 4
20188793 2010
16
Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. 4
19837910 2009
17
The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test. 4
19801957 2009
18
Steroid 17alpha-hydroxylase deficiency: functional characterization of four mutations (A174E, V178D, R440C, L465P) in the CYP17A1 gene. 4
19454579 2009
19
Genetic variation in human P450 oxidoreductase. 4
18930113 2009
20
Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. 4
18957504 2009
21
Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. 4
18559916 2008
22
Impairment of human CYP1A2-mediated xenobiotic metabolism by Antley-Bixler syndrome variants of cytochrome P450 oxidoreductase. 4
18455494 2008
23
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19. 4
18551037 2008
24
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity. 4
18433346 2008
25
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. 4
18230729 2008
26
Genetic and clinical features of p450 oxidoreductase deficiency. 4
18259105 2008
27
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. 4
17595315 2007
28
Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. 4
17505056 2007
29
Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. 4
17389698 2007
30
Benchmarking sets for molecular docking. 4
17154509 2006
31
Linking Antley-Bixler syndrome and congenital adrenal hyperplasia: a novel case of P450 oxidoreductase deficiency. 4
16906539 2006
32
Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. 4
16265639 2005
33
Sterol profiling of amniotic fluid: a routine method for the detection of distal cholesterol synthesis deficit. 4
16231320 2005
34
Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. 4
15793702 2005
35
Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. 4
15483095 2005
36
Compound heterozygous mutations of cytochrome P450 oxidoreductase gene (POR) in two patients with Antley-Bixler syndrome. 4
15264278 2004
37
Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome. 4
15266606 2004
38
Prenatal diagnosis of P450 oxidoreductase deficiency (ORD): a disorder causing low pregnancy estriol, maternal and fetal virilization, and the Antley-Bixler syndrome phenotype. 4
15316970 2004
39
Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. 4
15220035 2004
40
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. 4
14758361 2004
41
Apparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome. 4
14625002 2003
42
Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. 4
12917333 2003
43
Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. 4
12697746 2003
44
Abnormal sterol metabolism in a patient with Antley-Bixler syndrome and ambiguous genitalia. 4
12116245 2002
45
Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. 4
11742006 2002
46
Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. 4
9332650 1997
47
Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. 4
2932643 1985
48
The mechanism of Psoralen and Isopsoralen hepatotoxicity as revealed by hepatic gene expression profiling in SD rats. 38
31271704 2019
49
Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). 38
29633629 2019
50
Authors' reply: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019). 38
29633630 2019

Variations for Cytochrome P450 Oxidoreductase Deficiency

Copy number variations for Cytochrome P450 Oxidoreductase Deficiency from CNVD:

7
# CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 180701 4 109188149 109309027 Microdeletion LEF1 Cytochrome P450 oxidoreductase deficiency

Expression for Cytochrome P450 Oxidoreductase Deficiency

Search GEO for disease gene expression data for Cytochrome P450 Oxidoreductase Deficiency.

Pathways for Cytochrome P450 Oxidoreductase Deficiency

Pathways related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.35 POR POMC CYP21A2 CYP1A2 CYP17A1
2
Show member pathways
12.31 POMC CYP21A2 CYP17A1
3 11.37 POMC CYP21A2
4
Show member pathways
11.28 POMC CYP21A2 CYP17A1
5
Show member pathways
11.05 CYP1A2 CYP17A1
6
Show member pathways
10.62 CYP21A2 CYP1A2 CYP17A1
7
Show member pathways
10.58 CYP21A2 CYP17A1

GO Terms for Cytochrome P450 Oxidoreductase Deficiency

Cellular components related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.46 POR CYP21A2 CYP1A2 CYP17A1
2 organelle membrane GO:0031090 9.26 CYP21A2 CYP1A2
3 endoplasmic reticulum membrane GO:0005789 9.26 POR CYP21A2 CYP1A2 CYP17A1
4 intracellular membrane-bounded organelle GO:0043231 8.92 POR FGFR2 CYP21A2 CYP1A2

Biological processes related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 electron transport chain GO:0022900 9.46 POR CYP1A2
2 oxidation-reduction process GO:0055114 9.46 POR CYP21A2 CYP1A2 CYP17A1
3 lung development GO:0030324 9.43 FGFR2 CYP1A2
4 xenobiotic metabolic process GO:0006805 9.4 POR CYP1A2
5 post-embryonic development GO:0009791 9.37 FGFR2 CYP1A2
6 steroid biosynthetic process GO:0006694 9.32 CYP21A2 CYP17A1
7 sterol metabolic process GO:0016125 8.96 CYP21A2
8 glucocorticoid biosynthetic process GO:0006704 8.96 CYP21A2 CYP17A1
9 steroid metabolic process GO:0008202 8.8 CYP21A2 CYP1A2 CYP17A1

Molecular functions related to Cytochrome P450 Oxidoreductase Deficiency according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 oxidoreductase activity GO:0016491 9.56 POR CYP21A2 CYP1A2 CYP17A1
2 iron ion binding GO:0005506 9.33 CYP21A2 CYP1A2 CYP17A1
3 electron transfer activity GO:0009055 9.32 POR CYP1A2
4 heme binding GO:0020037 9.13 CYP21A2 CYP1A2 CYP17A1
5 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen GO:0016705 8.8 CYP21A2 CYP1A2 CYP17A1

Sources for Cytochrome P450 Oxidoreductase Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....